Skip to main content
JSPR
NASDAQ Life Sciences

Jasper Sets 1-for-30 Reverse Split to Cure Nasdaq Deficiencies

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.481
Mkt Cap
$15.972M
52W Low
$0.315
52W High
$2.42
52W Position info
53% above low
Off High info
80% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

JSPR sits 53% above its 52-week low of $0.315.

Summary

Jasper's 1-for-30 reverse stock split takes effect 12:01 a.m. ET November 6, 2026, cutting shares outstanding from about 33.3 million to approximately 1.11 million, subject to adjustment for fractional shares, under new CUSIP 471871301, with the stock expected to begin trading on a split-adjusted basis at the Nasdaq Capital Market open that day. The board set the 1-for-30 ratio and approved and authorized the Certificate of Amendment filing on October 23, 2026, within the 1-for-15 to 1-for-35 range (or any whole number in between) stockholders approved at the September 30, 2026 special meeting, and the Certificate of Third Amendment to the Second Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on November 2, 2026; the board could effect the split in its sole discretion at any time on or before December 31, 2026, and a press release announcing it was issued November 4, 2026. The split applies to Common Stock issuable upon exercise of outstanding warrants and stock options, with proportionate adjustments to exercise prices and warrants adjusted per their respective terms, and shares available under equity incentive plans are proportionately adjusted, while authorized Common Stock remains 490,000,000 shares and is not reduced, so authorized but unissued shares available for future issuance increase relative to shares outstanding. Each thirty shares of Voting Common Stock held by the company as treasury stock immediately prior to the effective time are combined into one share, old certificates represent the whole number of shares into which their shares were combined subject to fractional share treatment, and cash in lieu of fractional shares equals the fraction multiplied by the closing sales price on the Nasdaq Capital Market on November 5, 2026; stockholders of record will receive information from Continental Stock Transfer & Trust Company on their ownership and any fractional share payments. The move follows two Nasdaq deficiency notices — the minimum bid price and, in August, the $2.5 million minimum stockholders' equity rule — with a November 30 deadline hanging over the listing. The split fixes the share price arithmetic but does nothing for the underlying problems: going concern doubt, a CFO vacancy since October 9, and a resale shelf covering 284 million PIPE shares that dwarfs the current float. Watch whether the bid holds above $1 after the split takes effect; a second slide back under $1 would put the delisting back on the table.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Jasper's 1-for-30 reverse split takes effect 12:01 a.m. ET November 6, 2026, cutting shares outstanding from about 33.3 million to about 1.1 million; new CUSIP 471871301.

    • Effective Date and Trading — Post-split issued and outstanding shares are approximately 1.11 million, compared to approximately 33.3 million immediately prior, subject to adjustment for fractional shares. Common Stock is expected to begin trading on a split-adjusted basis at the market open on November 6, 2026.
    • Ratio Authorization — Stockholders approved a ratio range of 1-for-15 to 1-for-35 at the September 30, 2026 special meeting; the board set 1-for-30 and authorized the Certificate of Amendment on October 23, 2026, and could act on or before December 31, 2026.
    • Charter Amendment — The Certificate of Third Amendment to the Second Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on November 2, 2026. Authorized Common Stock remains 490,000,000 shares and is not reduced.
    • Warrants and Equity Plans — The split applies to Common Stock issuable upon exercise of outstanding warrants and stock options, with proportionate exercise price adjustments; shares available under equity incentive plans are proportionately adjusted, so fewer shares are subject to such plans.
    • Fractional Shares — Cash in lieu of fractional shares equals the fraction multiplied by the November 5, 2026 closing sales price on the Nasdaq Capital Market. Stockholders of record will receive information from Continental Stock Transfer & Trust Company on their ownership and any fractional share payments.
    • Share Mechanics — Each thirty shares of Voting Common Stock held as treasury stock immediately prior to the Effective Time combine into one share, and old certificates represent the whole number of shares into which their shares were combined, subject to fractional share treatment.
    All 14 details
    • Stockholders approved a ratio range of 1-for-15 to 1-for-35 (or any whole number in between) at the September 30, 2026 special meeting.
    • Board set the 1-for-30 ratio and approved and authorized the Certificate of Amendment filing on October 23, 2026.
    • Certificate of Third Amendment to the Second Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on November 2, 2026.
    • Reverse split applies to Common Stock issuable upon exercise of outstanding warrants and stock options, with proportionate adjustments to exercise prices; warrants adjusted per their respective terms.
    • Shares of Common Stock available for issuance under equity incentive plans proportionately adjusted for the reverse split ratio, so fewer shares are subject to such plans.
    • Authorized Common Stock remains 490,000,000 shares and is not reduced, so authorized but unissued shares available for future issuance increase relative to shares outstanding.
    • Post-split issued and outstanding approximately 1.11 million shares, compared to approximately 33.3 million shares immediately prior to the Reverse Split, subject to adjustment for fractional shares.
    • Cash in lieu of fractional shares equals the fraction multiplied by the closing sales price of Common Stock on the Nasdaq Capital Market on November 5, 2026.
    • Press release announcing the Reverse Stock Split issued November 4, 2026.
    • Board could effect the Reverse Stock Split in its sole discretion at any time on or before December 31, 2026.
    • Each thirty shares of Voting Common Stock issued and outstanding immediately prior to the Effective Time and held by the Corporation as treasury stock combined into one share.
    • Old Certificates represent, from and after the Effective Time, the whole number of shares into which the shares they represented were combined, subject to fractional share treatment.
    • Common Stock expected to begin trading on a Reverse Stock Split-adjusted basis on the Nasdaq Capital Market at the opening of the market on November 6, 2026.
    • Stockholders of record will receive information from Continental Stock Transfer & Trust Company regarding their stock ownership following the Reverse Stock Split and cash in lieu of fractional share payments, if applicable.

At the time of this announcement, JSPR was trading at $0.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16M. The 52-week trading range was $0.32 to $2.42. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

JSPR - Latest Insights

JSPR
Oct 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.501
Real-time Price: $0.501 info
Change: Reverse Stock Split info
Market Cap: $17.007M info
JSPR
Oct 14, 2026, 5:22 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.501
Real-time Price: $0.501 info
Change: Reverse Stock Split info
Market Cap: $17.007M info
JSPR
Oct 09, 2026, 4:53 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.5702
Real-time Price: $0.501 info
Change: Reverse Stock Split info
Market Cap: $17.007M info
JSPR
Oct 01, 2026, 5:29 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $0.598
Real-time Price: $0.501 info
Change: Reverse Stock Split info
Market Cap: $17.007M info
JSPR
Sep 28, 2026, 4:44 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.626
Real-time Price: $0.501 info
Change: Reverse Stock Split info
Market Cap: $17.007M info